Harris Labs, Neo-Pharm acquisitions by Canada's MDS Health Group will push CRO sales over C$100 mil.
Executive Summary
HARRIS LABS ACQUISITION BY MDS HEALTH GROUP and the MDS purchase of Neo-Pharm Labs will more than double MDS' annual pharmaceutical sciences revenue stream to over C$100 mil., the Toronto-based firm said Aug. 20. Total MDS annual sales were C$689 mil. in FY 1995 (ended March 31). Toronto-based MDS is Canada's largest technology-based health and life sciences firm, the company said.